Evidence map›Paper›PMID 42037832›Full record

ArticleCureus2026

Kaposi Sarcoma Presenting as Hemophagocytic Lymphohistiocytosis Mimicking Infection and Lymphoma: A Diagnostic Challenge.

Vahit C Cavdar, Çağdaş Kaya, Ayli Heydari, Chalil C Chatzi Chasan, Ayse Satilmisoglu, Yalçın Gökmen, Feray Akbas, Gülhan Özdemir, Gülben Erdem Huq, Esra S Kaya and 4 more

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Vahit C CavdarDepartment of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Çağdaş KayaDepartment of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Ayli HeydariDepartment of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Chalil C Chatzi ChasanDepartment of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Ayse SatilmisogluDepartment of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Yalçın GökmenDepartment of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Feray AkbasDepartment of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Gülhan ÖzdemirDepartment of Infectious Disease, University of Health Sciences, Istanbul Training and Research Hospital, İstanbul, TUR.
Gülben Erdem HuqDepartment of Pathology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Esra S KayaDepartment of Dermatology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Zeynep T DincerDepartment of Rheumatology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Ilkay GulturkDepartment of Medical Oncology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Kadir KarismazDepartment of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.
Sevil SadriDepartment of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kaposi sarcoma (KS) is an angioproliferative malignancy associated with human herpesvirus 8 and typically presents with cutaneous lesions. Visceral involvement and presentation as secondary hemophagocytic lymphohistiocytosis (HLH) are rare and may obscure the underlying diagnosis. A 45-year-old woman with hepatitis B carrier status and compensated cirrhosis presented with dizziness, fever, rash, fatigue, cytopenias, and hepatosplenomegaly. Laboratory evaluation revealed normocytic anemia, thrombocytopenia, elevated transaminases, and markedly increased inflammatory markers, prompting hospitalization for suspected infection and hematologic disease. Despite broad antimicrobial therapy and extensive investigations, her condition progressed with persistent inflammation, raising the suspicion of secondary HLH. Empirical treatment with etoposide and dexamethasone was initiated. Positron emission tomography demonstrated hypermetabolic bilateral axillary lymphadenopathy, and excisional biopsy of the right axillary lymph node revealed KS. The patient was transferred to oncology care, where therapy was changed to etoposide plus paclitaxel with clinical stabilization. KS presenting as secondary HLH is extremely uncommon and poses significant diagnostic challenges, particularly in the absence of typical cutaneous findings. This case underscores the importance of considering occult malignancy in patients with fever, cytopenias, and hepatosplenomegaly who do not respond to conventional therapy. Timely tissue diagnosis is crucial in patients with suspected HLH when the underlying cause is unclear, as the early identification of malignancy can significantly alter management and improve outcomes.

Indexed as

feverhemophagocytic lymphohistiocytosishepatitis bhepatomegalykaposi sarcomasplenomegaly

Identifiers

PMID42037832
PMCPMC13104699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.